CN100398138C - A traditional Chinese medicine for antidepressant and treating hypothermia - Google Patents
A traditional Chinese medicine for antidepressant and treating hypothermia Download PDFInfo
- Publication number
- CN100398138C CN100398138C CNB2004100098171A CN200410009817A CN100398138C CN 100398138 C CN100398138 C CN 100398138C CN B2004100098171 A CNB2004100098171 A CN B2004100098171A CN 200410009817 A CN200410009817 A CN 200410009817A CN 100398138 C CN100398138 C CN 100398138C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- antidepressant
- mice
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种抗抑郁和治疗低体温症的中药,包括远志、郁金、香附和甘草。本发明的中药克服了化学类抗抑郁药的毒性,克服了国内外抗抑郁植物药对机体的客观生理指标影响不明显的缺陷。使小鼠利血平抑郁模型的体温明显升高,低、中、高三个剂量分别可升高体温1.69℃、2.22℃和2.63℃。脑组织中去甲肾上腺素、多巴胺和5-羟色胺的含量比利血平抑郁模型组也明显升高。小鼠抑郁症状也比对照组明显减轻,上眼睑下垂现象得以改善。小鼠悬尾不动时间缩短,自主活动性增强。表明本中药制剂对抑郁症有明显的治疗作用,是一种疗效明确、安全、理想的抗抑郁药,具有良好的开发前景。The invention discloses a traditional Chinese medicine for antidepressant and treating hypothermia, which comprises polygala, turmeric, rhizoma rhizome and licorice. The traditional Chinese medicine of the invention overcomes the toxicity of chemical antidepressants, and overcomes the defect that domestic and foreign antidepressant herbal medicines have no obvious influence on the objective physiological indicators of the body. The body temperature of the mouse reserpine depression model was significantly increased, and the low, medium, and high doses could increase the body temperature by 1.69°C, 2.22°C, and 2.63°C, respectively. The content of norepinephrine, dopamine and 5-hydroxytryptamine in the brain tissue was also significantly higher than that of the reserpine depression model group. The depressive symptoms of the mice were also significantly reduced compared with the control group, and the ptosis of the upper eyelid was improved. The tail-suspension time of the mice was shortened, and the voluntary activity was enhanced. It shows that the traditional Chinese medicine preparation has obvious therapeutic effect on depression, is a clear curative effect, safe and ideal antidepressant, and has good development prospect.
Description
技术领域 technical field
本发明涉及一种抗抑郁和治疗低体温症的中药The invention relates to a traditional Chinese medicine for antidepressant and treating hypothermia
背景技术 Background technique
20世纪50年代初,第一代抗抑郁药单胺氧化酶抑制剂和三环类抗抑郁药开始应用于临床,但由于有广泛和严重的副作用,其应用受到严重的限制[1-13];60年代起开发的第二代抗抑郁药以杂环类为主,主要有可逆性单胺氧化酶抑制剂和选择性5-羟色胺再摄取抑制剂。该类药物虽较第一代抗抑郁药安全性有所提高,但疗效仍无显著提高,且副作用仍较大,如恶心、焦虑、食欲降低和性功能下降等,所以迄今尚未有理想的抗抑郁药问世。2004年6月2日全球著名的制药企业葛兰素史克在美国纽约州被控所生产的抗抑郁药帕罗西汀既无效也不安全。今年11月7日英国《观察家报》报道英国议会对该公司进行调查。最近美国食品药品管理局(FDA)发出全面警告,儿童应用抗抑郁药(化学药)有增加自杀的危险。鉴于西药的严重副作用,许多研究者对西药治疗抑郁症逐渐失去信心,转而从传统植物药中寻找有效的治疗药物。90年代欧洲科学家从药用植物中提取的金丝桃素已用于抑郁症的治疗,并载入德国、俄罗斯、波兰、瑞士等国家药典[14]。但在美国的同样两次临床试验均无结果[15,16]。In the early 1950s, the first generation of antidepressants monoamine oxidase inhibitors and tricyclic antidepressants began to be used clinically, but their application was severely limited due to extensive and serious side effects [1-13] ; in the 1960s The second-generation antidepressants developed since then are mainly heterocyclics, mainly including reversible monoamine oxidase inhibitors and selective serotonin reuptake inhibitors. Although the safety of these drugs has improved compared with the first-generation antidepressants, the curative effect has not been significantly improved, and the side effects are still relatively large, such as nausea, anxiety, decreased appetite and decreased sexual function, so there is no ideal antidepressant so far. Depressants came out. On June 2, 2004, GlaxoSmithKline, a world-renowned pharmaceutical company, was accused in New York State of the United States of producing the antidepressant Paroxetine, which was neither effective nor safe. On November 7 this year, the British "Observer" reported that the British Parliament was investigating the company. Recently, the US Food and Drug Administration (FDA) issued a comprehensive warning that the use of antidepressants (chemical drugs) in children has an increased risk of suicide. In view of the serious side effects of western medicine, many researchers have gradually lost confidence in the treatment of depression with western medicine, and turned to traditional herbal medicine to find effective therapeutic drugs. Hypericin extracted from medicinal plants by European scientists in the 1990s has been used for the treatment of depression and has been included in the national pharmacopoeias of Germany, Russia, Poland, and Switzerland [14] . But the same two clinical trials in the United States had no results [15,16] .
本中药组方可明显改善小鼠抑郁症模型的症状,升高利血平抑郁模型小鼠体温,升高脑组织中单胺类递质的含量。急性毒性试验不能测出LD50,最大耐受量试验也未见明显的毒性反应。表明远志组方是一种疗效明确、安全、理想的抗抑郁药。The traditional Chinese medicine prescription can obviously improve the symptoms of the mouse depression model, increase the body temperature of the reserpine depression model mouse, and increase the content of monoamine transmitters in the brain tissue. The LD 50 could not be measured in the acute toxicity test, and no obvious toxic reaction was found in the maximum tolerated dose test. It shows that Polygala Prescription is a clear, safe and ideal antidepressant.
发明内容 Contents of the invention
为了解决经典抗抑郁药物副作用大且广泛的问题,本发明的目的是提供一种疗效确切、效果明显、使用方便安全的抗抑郁中药,其剂型称为金志抗抑郁片和金志抗抑郁胶囊。In order to solve the problem of large and extensive side effects of classic antidepressants, the object of the present invention is to provide an antidepressant traditional Chinese medicine with definite curative effect, obvious effect, convenient and safe use, and its dosage forms are called Jinzhi Kangdepress Tablets and Jinzhi Kangdepress Capsules.
本发明的中药复方有如下组分:远志、郁金、香附、甘草。The traditional Chinese medicine compound of the present invention has the following components: polygala, turmeric, Cyperus cyperi and licorice.
将方中各药按8∶5∶5∶1的比例组方,经药学研究确定了制备工艺,制成片剂和胶囊剂型。成人每天服用相当与生药量19g,分两次服用。Each drug in the prescription is formulated according to the ratio of 8:5:5:1, the preparation process is determined through pharmaceutical research, and the dosage forms of tablets and capsules are made. Adults take 19g equivalent to the crude drug amount every day, and take it twice.
用胶囊剂型的低、中、高三个剂量的抗抑郁药给昆明小鼠灌胃,治疗由利血平引起的抑郁症。观察小鼠的上眼睑下垂的情况变化、体温的变化及脑组织中单胺类递质含量的变化。Three doses of antidepressants in the form of capsules were administered to Kunming mice to treat depression induced by reserpine. Observe the changes of the ptosis of the upper eyelid, the body temperature and the content of monoamine transmitters in the brain tissue of the mice.
本中药组方能阻遏利血平所引起的上眼睑下垂作用,总体P<0.01。低剂量组与模型组比P值接近0.05,中剂量和高剂量与模型组比P值<0.01。The prescription of this traditional Chinese medicine can inhibit the drooping effect of the upper eyelid caused by reserpine, the overall P<0.01. The P value of the ratio between the low-dose group and the model group was close to 0.05, and the P value of the ratio between the middle-dose and high-dose group and the model group was <0.01.
中药组方可明显遏制利血平所引起的体温下降。低、中、高各剂量组与模型组比P值均小于0.01,各剂量组比抑郁症模型组小鼠的低体温分别高出1.69℃、2.22℃和2.63℃。The prescription of traditional Chinese medicine can obviously curb the drop of body temperature caused by reserpine. The P values of the ratios between the low, medium and high dose groups and the model group were all less than 0.01, and the hypothermia of the mice in each dose group was 1.69°C, 2.22°C and 2.63°C higher than that of the depression model group, respectively.
使用中药的各剂量组小鼠脑组织中5-羟色胺(5-HT)、多巴胺(DA)和去甲肾上腺素(NE)的含量均明显高于抑郁症模型对照组。The contents of 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE) in the brain tissue of mice in each dosage group of traditional Chinese medicine were significantly higher than those in the depression model control group.
在小鼠悬尾试验中,各中药剂量组小鼠4分钟内的不动时间比正常组明显缩短(P<0.01),并且有一定的量效关系。In the mouse tail suspension test, the immobility time of the mice within 4 minutes of each Chinese medicine dosage group was significantly shorter than that of the normal group (P<0.01), and there was a certain dose-effect relationship.
该中药组方符合中医抗抑郁的组方原理,除了可以使上述的客观指标明显改善外,还可使抑郁症模型小鼠的自主活动增多,强迫性嗜咬活动增强,使小鼠抑郁症状得到显著改善,其效果与丙咪嗪抗抑郁药相当。The traditional Chinese medicine formula conforms to the anti-depressant formula principle of traditional Chinese medicine. In addition to significantly improving the above objective indicators, it can also increase the voluntary activities of the depression model mice, enhance the compulsive biting activity, and improve the depressive symptoms of the mice. Significant improvement, its effect is comparable to imipramine antidepressant.
具体实施方式 Detailed ways
1.制备工艺1. Preparation process
将远志、郁金、香附、甘草按8∶5∶5∶1的重量比例组方,经药学研究确定制备工艺如下:将郁金和香附用70%的乙醇回流提取挥发油,将挥发油用β-环糊精包结。上述药渣与远志和甘草混合,用7倍的水煎2小时,提取2次,滤过、2000转离心,与包结物混合,浓缩干燥。加辅料和矫味剂制成糖衣片或胶囊剂型。Polygala, Curcuma Cyperi, Radix Cyperi and Glycyrrhiza were formulated according to the weight ratio of 8:5:5:1, and the preparation process was determined through pharmaceutical research as follows: the turmeric and Rhizoma Cyperi were refluxed with 70% ethanol to extract the volatile oil, and the volatile oil was extracted with β - Cyclodextrin inclusions. The above medicinal residues are mixed with polygala and licorice, decocted with 7 times of water for 2 hours, extracted twice, filtered, centrifuged at 2000 rpm, mixed with inclusions, concentrated and dried. Add auxiliary materials and flavoring agents to make sugar-coated tablets or capsules.
2.抗抑郁实验2. Antidepressant experiment
实验动物为雄性昆明小鼠,体重20±2g,用利血平5mg/kg皮下注射复制抑郁症模型。分为正常组、模型组、中药低剂量组、中药中剂量组、中药高剂量组、丙咪嗪组,每组10只动物。胃饲给药。The experimental animals are male Kunming mice with a body weight of 20±2 g, and the depression model is reproduced by subcutaneous injection of reserpine 5 mg/kg. They were divided into normal group, model group, low-dose Chinese medicine group, middle-dose Chinese medicine group, high-dose Chinese medicine group and imipramine group, with 10 animals in each group. Gastric feeding.
正常组皮下注射生理盐水0.1ml,胃饲生理盐水0.5ml。模型组皮下注射利血平5mg/kg,胃饲生理盐水0.5ml。中药低剂量组皮下注射利血平5mg/kg,胃饲中药相当1g(生药)/kg(约20mg/只)。中药中剂量组皮下注射利血平5mg/kg,胃饲中药相当5.5g(生药)/kg(约110mg/只)。中药高剂量组皮下注射利血平5mg/kg,胃饲中药相当11g(生药)/kg(约220mg/只)。丙咪嗪组皮下注射利血平5mg/kg,胃饲丙咪嗪20mg/kg。观测下述指标:In the normal group, 0.1 ml of normal saline was injected subcutaneously, and 0.5 ml of normal saline was fed into the stomach. The model group was subcutaneously injected with reserpine 5 mg/kg, and 0.5 ml of normal saline was fed into the stomach. In the low dose group of traditional Chinese medicine, 5 mg/kg of reserpine was subcutaneously injected, and the equivalent of 1 g (crude drug)/kg (about 20 mg/monkey) of traditional Chinese medicine was fed into the stomach. In the traditional Chinese medicine group, 5 mg/kg of reserpine was injected subcutaneously, and 5.5 g (crude drug)/kg (about 110 mg/monkey) of traditional Chinese medicine was fed into the stomach. In the high-dose group of traditional Chinese medicine, 5 mg/kg of reserpine was injected subcutaneously, and 11 g (crude drug)/kg (about 220 mg/monkey) of traditional Chinese medicine was fed into the stomach. In the imipramine group, 5 mg/kg reserpine was injected subcutaneously, and 20 mg/kg imipramine was fed into the stomach. Observe the following indicators:
(1)上眼睑下垂试验:1小时后观察小鼠眼睑30秒。(1) Upper blepharoptosis test: After 1 hour, the eyelids of the mice were observed for 30 seconds.
(2)小鼠体温下降阻遏实验:给药18小时后再次胃饲相应的药物,过1小时后测量小鼠肛温(2) Mouse body temperature drop suppression experiment: 18 hours after the administration, the corresponding drug was fed into the stomach again, and the anal temperature of the mice was measured after 1 hour.
(3)小鼠脑组织单胺(NE、DA、5-HT)含量测定:(模型同上)。取脑组织,(3) Determination of monoamine (NE, DA, 5-HT) content in mouse brain tissue: (the model is the same as above). take brain tissue,
用荧光法测定单胺递质含量。The content of monoamine transmitters was determined by fluorescence method.
(4)小鼠悬尾试验:悬尾6min。观察后4min内的不动时间。(4) Mouse tail suspension test: tail suspension for 6 minutes. The immobility time within 4min after observation.
(5)大鼠游泳绝望试验、小鼠游泳绝望试验。(5) Rat swimming despair test, mouse swimming despair test.
(6)30min后放入GJ-8506小鼠活动记数仪内,测定10min内的自发活动次数。(6) After 30 minutes, put it into a GJ-8506 mouse activity counter, and measure the number of spontaneous activities within 10 minutes.
实验结果:Experimental results:
(1).上眼睑下垂试验:重新放置小鼠,观察眼睑30秒,对眼睑下垂进行评分,闭眼=++++、眼睑闭3/4=+++、眼睑闭1/2=++、眼睑闭1/4=+、不闭眼=0。对观察到的等级结果进行秩和检验。(1). Upper eyelid ptosis test: place the mouse again, observe eyelids for 30 seconds, and score eyelid ptosis, eyes closed = ++++, eyelids closed 3/4 = +++, eyelids closed 1/2 = + +, eyelids closed 1/4 = +, eyes not closed = 0. A rank sum test was performed on the observed ranking results.
抗抑郁中药拮抗利血平上眼睑下垂试验的秩和检验(给药1小时后)Rank sum test of antidepressant traditional Chinese medicine antagonizing reserpine upper eyelid ptosis test (1 hour after administration)
注:++++:上眼睑全闭、+++:上眼睑闭3/4、++:上眼睑闭1/2、+:上眼睑闭1/4、-:上眼睑全睁Note: ++++: upper eyelid fully closed, +++: upper eyelid closed 3/4, ++: upper eyelid closed 1/2, +: upper eyelid closed 1/4, -: upper eyelid fully open
H=12/(N(N+1))∑R2/n-3(N+1)=14.45085 c=1-∑(t3-t)/(N3-N)=0.93058
k=4 v=k-1=3 X2值0.005·3=12.48,Hc>X2值0.05·3· P<0.005k=4 v=k-1=3 X 2 value 0.005·3 =12.48, Hc>X 2 value 0.05·3· P<0.005
本中药组方能阻遏利血平所引起的上眼睑下垂作用,总体P<0.01。The prescription of this traditional Chinese medicine can inhibit the drooping effect of the upper eyelid caused by reserpine, the overall P<0.01.
进一步用t检验法进行两两比较:Further use the t test method for pairwise comparisons:
抗抑郁中药拮抗利血平上眼睑下垂试验两两比较的秩和t检验Rank sum t-test for pairwise comparison of antidepressant traditional Chinese medicine antagonizing reserpine upper eyelid ptosis test
低剂量组与模型组比P值接近0.05,中剂量和高剂量与模型组比P值<0.001。The P value of the ratio between the low-dose group and the model group was close to 0.05, and the P value of the ratio between the middle-dose and high-dose group and the model group was <0.001.
(2)小鼠体温下降阻遏试验:(2) Mouse body temperature drop suppression test:
用利血平制备小鼠模型,同时给予治疗药物,18小时后再次给予治疗药物,2小时后测定肛温。The mouse model was prepared with reserpine, and the therapeutic drug was administered at the same time, and the therapeutic drug was given again 18 hours later, and the rectal temperature was measured 2 hours later.
抗抑郁中药对利血平诱导小鼠体温下降试验的阻遏作用(℃)Inhibition of antidepressant traditional Chinese medicine on reserpine-induced hypothermia test in mice (℃)
注:各剂量组与模型组比较P<0.01Note: P<0.01 for each dose group compared with the model group
高、中、低三个剂量,可使抑郁症模型小鼠的低体温比模型组分别升高1.69℃、2.22℃和2.63℃。High, medium and low doses can increase the hypothermia of the depression model mice by 1.69°C, 2.22°C and 2.63°C, respectively, compared with the model group.
(3)小鼠脑组织儿茶酚胺含量测定:(3) Determination of catecholamine content in mouse brain tissue:
小鼠分组、模型制备、给药方式均与实验3相同,最后一次给药2小时后处死,立即取大脑组织,按文献(17)的方法处理,提取儿茶酚胺(5-HT、DA、NE)。用改进的荧光方法测定。The mouse grouping, model preparation, and administration methods were all the same as those in Experiment 3. They were killed 2 hours after the last administration, and the brain tissue was taken immediately, and processed according to the method in literature (17) to extract catecholamines (5-HT, DA, NE) . Determined by a modified fluorescence method.
抗抑郁中药对抑郁大鼠脑组织神经递质含量的影响(ng/g湿组织)Effects of Antidepressant Traditional Chinese Medicine on Neurotransmitter Content in Brain Tissue of Depressed Rats (ng/g wet tissue)
注:**:各药物剂量组与模型组比P<0.01。Note: ** : The ratio of each drug dose group to the model group is P<0.01.
脑组织中5-羟色胺(5-HT)、多巴胺(DA)和去甲肾上腺素(NE)的含量均明显高于抑郁症模型对照组。The contents of 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE) in the brain tissue were significantly higher than those in the depression model control group.
(4)小鼠悬尾试验(4) Mouse tail suspension test
小鼠随机分组,每组15只,给药1小时后将小鼠尾部(距尾尖1cm处)用胶布粘在20×25×25cm的箱内。头距底部5cm,倒悬6min,记录后4min内小鼠不动的时间。The mice were divided into random groups, 15 in each group, and the tails of the mice (1 cm away from the tail tip) were glued in a box of 20×25×25 cm after 1 hour of administration. The head is 5 cm from the bottom, hang upside down for 6 minutes, and record the time that the mouse does not move within 4 minutes afterward.
抗抑郁中药对小鼠悬尾实验4min内不动的时间(s)The immobility time (s) of antidepressant traditional Chinese medicine on mice tail suspension test within 4min
各给药组与正常组比,小鼠的不动时间明显缩短。Compared with the normal group, the immobility time of the mice in each administration group was significantly shortened.
本发明除了可以使上述的客观指标明显改善外,还可使抑郁症模型小鼠的自主活动增多,强迫性嗜咬活动增强,使小鼠抑郁症状得到显著改善,其效果与丙咪嗪抗抑郁药相当。The present invention can not only obviously improve the above-mentioned objective indicators, but also increase the autonomous activities of the depression model mice, enhance the compulsive biting activity, and significantly improve the depressive symptoms of the mice. The medicine is quite.
由于该组方不仅可以改善用利血平、四苯嗪等药物所造成的抑郁模型的症状,也能改善由多种刺激所造成的抑郁症状,其效果与经典的抗抑郁药丙咪嗪相当。Since this formula can not only improve the symptoms of depression models caused by drugs such as reserpine and tetrabenzine, but also improve the symptoms of depression caused by various stimuli, its effect is equivalent to that of the classic antidepressant imipramine .
对该组方进行拆方实验,并用上述指标进行验证,证明起关键作用的是远志。中医认为郁症由情志不遂、肝郁气滞、脾失运化,以致气滞血郁、肝气失于调达所致,因此传统治疗郁症以理气解郁为治则,而诸郁皆伤神,治郁当宁心。本方以解郁安神、舒肝理气、养血宁心等中药配伍,共奏舒肝理气、解郁安神之功效。因此本组方中选用了郁金、香附、甘草等协同远志的特殊药理作用从而强化了抗抑郁作用,起到良好的治疗效果。现代医学认为抑郁症不仅仅是单胺类递质的过度耗竭,而是多种因素共同作用的结果,如兴奋性氨基酸(NMDA)受体系统等。传统中药对这种多种因素引起的疾病有明显优势,根据君、臣、佐、使的理论,对机体进行整体调理。所以该组方对治疗多种类型的抑郁症效果显著。The recipe was disassembled and verified with the above indicators, which proved that polygala played a key role. Traditional Chinese medicine believes that depression is caused by emotional failure, liver depression and qi stagnation, spleen failure, resulting in qi stagnation and blood stagnation, and liver qi failure. Therefore, the traditional treatment of depression is to regulate qi and relieve depression, and all depressions Hurt the mind, treat depression and calm the heart. This prescription is compatible with traditional Chinese medicines such as relieving stagnation and calming the nerves, soothing the liver and regulating qi, nourishing blood and calming the heart, and has the effects of soothing the liver and regulating qi, relieving stagnation and calming the nerves. Therefore, the special pharmacological effects of turmeric, Cyperus cyperi, and licorice were used in this prescription to strengthen the antidepressant effect and play a good therapeutic effect. Modern medicine believes that depression is not just the excessive depletion of monoamine transmitters, but the result of multiple factors, such as the excitatory amino acid (NMDA) receptor system. Traditional Chinese medicine has obvious advantages in treating diseases caused by multiple factors. According to the theory of monarch, minister, assistant and envoy, it can regulate the body as a whole. Therefore, this formula has a significant effect on treating various types of depression.
本中药组方急性毒性试验不能测出LD50,最大耐受量试验也未见明显的毒性反应。表明该组方是一本中药组方可明显改善小鼠抑郁症模型的症状,升高利血平抑郁模型小鼠体温,升高脑组织中单胺类递质的含量。急性毒性试验不能测出LD50,最大耐受量试验也未见明显的毒性反应。表明远志组方是一种疗效明确、安全、理想的抗抑郁药。种疗效明确、安全、理想的抗抑郁药。The acute toxicity test of this traditional Chinese medicine prescription could not detect the LD 50 , and no obvious toxic reaction was found in the maximum tolerated dose test. It shows that this group of prescriptions is a traditional Chinese medicine group that can significantly improve the symptoms of the mouse depression model, increase the body temperature of the reserpine depression model mice, and increase the content of monoamine transmitters in the brain tissue. The LD 50 could not be measured in the acute toxicity test, and no obvious toxic reaction was found in the maximum tolerated dose test. It shows that Polygala Prescription is a clear, safe and ideal antidepressant. A clear, safe and ideal antidepressant.
参考文献references
1.APA:Am J Psychiatry 1993,150(4):1-161. APA: Am J Psychiatry 1993, 150(4): 1-16
2.Rodin G...Depression in the medically ill,New York,Brunner/Mazel Inc.1991;310-3222. Rodin G...Depression in the medically ill, New York, Brunner/Mazel Inc.1991; 310-322
3.Nierenberg AA:J Clin Psychiatry 1993;53(9):19-243. Nierenberg AA: J Clin Psychiatry 1993; 53(9): 19-24
4.Lejoyeux M:Acta Psychiatr Scand 1992;85:249-2554. Lejoyeux M: Acta Psychiatr Scand 1992; 85: 249-255
5.喻东山 国外医学 精神病学分册 1994,21(1):12-165. Yu Dongshan Foreign Medicine Psychiatry Volume 1994, 21(1): 12-16
6.Richelson E:J Clin Psychiatry 1991;52(6):4-106. Richelson E: J Clin Psychiatry 1991; 52(6): 4-10
7.Nierenberg AA...J Clin Psychiatry 1991;52(6)40-477. Nierenberg AA...J Clin Psychiatry 1991; 52(6)40-47
8.Smiley A:J Clin Psychiatry 1987;48(12):22-288. Smiley A: J Clin Psychiatry 1987; 48(12): 22-28
9.Poose SP...J Clin Psychiatry 1992;53(9):25-319. Poose SP... J Clin Psychiatry 1992; 53(9): 25-31
10.Taylor CB...J Psychiatry Res 1991;24(2):43-4910. Taylor CB... J Psychiatry Res 1991; 24(2): 43-49
11.Misri S...Int′l J Psychiatry in Medicine 1991;21:157-17111. Misri S...Int′l J Psychiatry in Medicine 1991; 21:157-171
12.Segraves RT:Arch Gen Psychiatry 1989;46:275-28412. Segraves RT: Arch Gen Psychiatry 1989; 46: 275-284
13.Dilsaver SC:Acta Psychiatry Scand 1989;79:113-11913. Dilsaver SC: Acta Psychiatry Scand 1989; 79: 113-119
14.国外医药-植物药分册 1998,13.(6):29214. Foreign Medicine-Phytomedicine Volume 1998, 13.(6): 292
15.国外医药-植物药分册 2002,17(3):11015. Foreign Medicine-Herbal Medicine Volume 2002, 17(3): 110
16.国外医药-植物药分册 2002,17(5):22516. Foreign Medicine-Herbal Drug Volume 2002, 17(5): 225
17.李仪奎.中药药理实验方法学,上海科学技术出版社,1991.181-18317. Li Yikui. Pharmacological Experimental Methodology of Traditional Chinese Medicine, Shanghai Science and Technology Press, 1991.181-183
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100098171A CN100398138C (en) | 2004-11-18 | 2004-11-18 | A traditional Chinese medicine for antidepressant and treating hypothermia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100098171A CN100398138C (en) | 2004-11-18 | 2004-11-18 | A traditional Chinese medicine for antidepressant and treating hypothermia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1778381A CN1778381A (en) | 2006-05-31 |
CN100398138C true CN100398138C (en) | 2008-07-02 |
Family
ID=36768918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100098171A Expired - Fee Related CN100398138C (en) | 2004-11-18 | 2004-11-18 | A traditional Chinese medicine for antidepressant and treating hypothermia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100398138C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102451442B (en) * | 2010-11-02 | 2014-06-25 | 王磊 | Extraction process of anti-depression Chinese medicament |
CN106491895A (en) * | 2016-01-22 | 2017-03-15 | 中卫清华园生物科技有限公司 | A kind of health medicine for treating depression |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198349A (en) * | 1998-05-14 | 1998-11-11 | 邹文辉 | Medicine for curing pulmonary heart disease |
-
2004
- 2004-11-18 CN CNB2004100098171A patent/CN100398138C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198349A (en) * | 1998-05-14 | 1998-11-11 | 邹文辉 | Medicine for curing pulmonary heart disease |
Non-Patent Citations (1)
Title |
---|
宁心定悸汤治疗惊悸25例. 张喜奎.陕西中医,第11卷第3期. 1990 * |
Also Published As
Publication number | Publication date |
---|---|
CN1778381A (en) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1994451B (en) | Chinese medicinal composition for treating depression, its preparation method and application | |
CN105725211A (en) | Food health product for improving sleep and preparation method thereof | |
CN106573029A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
CN101780227B (en) | Traditional Chinese medicine composition for treating acute stroke and preparation method thereof | |
CN106728261B (en) | Pharmaceutical composition for treating insomnia | |
CN101129971B (en) | Traditional Chinese medicine composition for treating women's menorrhalgia and menoxenia, and method of preparing the same | |
CN111437338A (en) | Application of traditional Chinese medicine composition in treating skin diseases | |
CN101288761B (en) | Chinese tmedicine preparation for treating depression and its preparation method | |
CN106659755A (en) | Methods, drugs and drug formula for processing mammal sexual dysfunction | |
CN103933487A (en) | Compound traditional Chinese medicament for treating depression | |
CN101181285A (en) | Application of astragaloside IV in the preparation of drugs for treating neurodegenerative diseases | |
CN109289009A (en) | A kind of Chinese medicine composition and its preparation method and application | |
KR101987418B1 (en) | A composition comprising herbal mixture extract for neuroprotection | |
CN104706881B (en) | A kind of health products with regulation sleep function | |
CN100398138C (en) | A traditional Chinese medicine for antidepressant and treating hypothermia | |
CN103405719A (en) | Medicament for treatment of depression | |
CN103705774A (en) | Compound composition with effect of treating depression as well as preparation method and application thereof | |
Mohajeri et al. | Antidepressant and antianxiety properties of saffron | |
CN107334954B (en) | Traditional Chinese medicine composition for treating Parkinson's disease and preparation method thereof | |
CN116672427A (en) | Natural plant volatile oil for relieving dizziness and headache as well as preparation method and application thereof | |
CN112569237B (en) | Application of imatinib and its derivatives in combination with nicotine or its analogues or compounds in the prevention and treatment of nicotine addiction and relapse | |
CN103566349B (en) | A kind of pharmaceutical composition for the treatment of hyperglycemia hyperlipidemia | |
JP2007153816A (en) | Fatigue improver composition | |
CN108079049A (en) | Radix codonopsis and Radix Astragali composition is used to prepare the purposes of the drug for the treatment of depression | |
CN104288670B (en) | A pharmaceutical composition for treating or/and preventing Alzheimer's disease, its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080702 Termination date: 20181118 |